1004.441 Refractory and intractable epilepsy treatment and research.—
(1) As used in this section, the term “low-THC cannabis” means “low-THC cannabis” as defined in s. 381.986 that is dispensed only from a dispensing organization as defined in s. 381.986.
(2) Notwithstanding chapter 893, state universities with both medical and agricultural research programs, including those that have satellite campuses or research agreements with other similar institutions, may conduct research on cannabidiol and low-THC cannabis. This research may include, but is not limited to, the agricultural development, production, clinical research, and use of liquid medical derivatives of cannabidiol and low-THC cannabis for the treatment for refractory or intractable epilepsy. The authority for state universities to conduct this research is derived from 21 C.F.R. parts 312 and 316. Current state or privately obtained research funds may be used to support the activities authorized by this section.
History.—s. 6, ch. 2014-157.
Section: Previous 1004.39 1004.40 1004.41 1004.42 1004.43 1004.435 1004.44 1004.441 1004.444 1004.445 1004.447 1004.4471 1004.4472 1004.45 1004.46 NextLast modified: September 23, 2016